SRPT
Sarepta Therapeutics, Inc. · Healthcare · Biotechnology
Input momentum (manajer yang sebanding):
keluasan pemegang -6.2% ·
aliran saham +24.2% ·
posisi baru bersih -6.7%
· formula
Akumulasi terkonsentrasi: saham yang meningkat di antara lebih sedikit pemegang
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q2 2025
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | -1 | 19.39K | $353,037 | n/a | −1 |
| Q2 2026 | 109 | +2 | 83.38M | $1.50B | +13 | −12 |
| Q1 2026 | 111 | +1 | 76.41M | $1.66B | +6 | −6 |
| Q4 2025 | 110 | +2 | 75.97M | $1.63B | +3 | n/a |
| Q3 2025 | 17 | 0 | 44.07M | $848.49M | +2 | −3 |
| Q2 2025 | 15 | -1 | 40.14M | $686.46M | +1 | −2 |
| Q1 2025 | 13 | -1 | 11.03M | $703.96M | +1 | −2 |
| Q4 2024 | 14 | -1 | 10.27M | $1.25B | +2 | −3 |
| Q3 2024 | 14 | +1 | 7.65M | $955.24M | +1 | n/a |
| Q2 2024 | 13 | n/a | 7.85M | $1.24B | n/a | n/a |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (pasif) | 12.12M | n/a | $207.17M | 0.0% | n/c | 1 | SEC ↗ ×18 |
| 2 | The Vanguard Group ✦ (pasif) | 9.16M | n/a | $156.64M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 3 | State Street Global Advisors ✦ (pasif) | 4.70M | +15.4% | $80.28M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | D. E. Shaw & Co. ✦ | 4.48M | +101548.6% | $76.58M | 0.1% | ▲ Add | 5 | SEC ↗ ×2 |
| 5 | Wellington Management ✦ | 2.53M | -4.4% | $43.27M | 0.0% | ▼ Trim | 5 | SEC ↗ ×5 |
| 6 | Two Sigma Investments ✦ | 2.16M | +292.4% | $36.97M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 7 | Geode Capital Management ✦ (pasif) | 1.88M | +3.0% | $32.08M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 8 | Millennium Management ✦ | 1.06M | +413.3% | $18.16M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 9 | Norges Bank ✦ (pasif) | 913.41K | -23.4% | $15.62M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 10 | Renaissance Technologies ✦ | 624.48K | Baru | $10.68M | 0.0% | New | 1 | SEC ↗ |
| 11 | Citadel Advisors ✦ | 302.16K | +28.1% | $5.17M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 125.98K | +2239.4% | $2.15M | 0.0% | ▲ Add | 3 | SEC ↗ ×3 |
| 13 | T. Rowe Price ✦ | 76.78K | -67.8% | $1.31M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 14 | Fisher Asset Management ✦ | 12.91K | +1.2% | $220,761 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 15 | Fidelity (FMR) ✦ | 8.20K | n/a | $140,137 | 0.0% | n/c | 1 | SEC ↗ ×2 |
"Their weight" = porsi posisi dari nilai ekuitas 13F yang dilaporkan manajer tersebut: ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Renaissance Technologies | $10.68M | 0.0% |
Telah keluar
| Marshall Wace | $1.74M | adalah 0.0% |
| Bridgewater Associates | $1.26M | adalah 0.0% |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 339 pemegang, 102.41M saham, $2.16B dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang sekuritas ini yang dilacak: jumlah kepemilikan bersama, bukan hubungan fundamental.